MORGAN STANLEY PLC/CALL/MERCK & CO./125/0.1/20.12.24 Share Price

Warrant

DE000MB70QZ4

Real-time Bid/Ask 05:30:16 08/07/2024 pm IST
0.88 EUR / 0.9 EUR +12.66% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./125/0.1/20.12.24
Current month-24.04%
1 month-27.52%
Date Price Change
08/24/08 0.85 +7.59%
05/24/05 0.79 +1.28%
04/24/04 0.78 -4.88%
03/24/03 0.82 -10.87%
02/24/02 0.92 -6.12%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 12:22 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB70QZ
ISINDE000MB70QZ4
Date issued 06/06/2023
Strike 125 $
Maturity 20/12/2024 (165 Days)
Parity 10 : 1
Emission price 1.03
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.176
Delta0.58x
Omega 7.788
Premium6.35x
Gearing13.34x
Moneyness 1.012
Difference Strike -1.45 $
Difference Strike %-1.16%
Spread 0.03
Spread %3.37%
Theoretical value 0.8950
Implied Volatility 24.58 %
Total Loss Probability 47.51 %
Intrinsic value 0.1339
Present value 0.7611
Break even 134.70 €
Theta-0.02x
Vega0.03x
Rho0.03x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus